Join the 200th Anniversary Celebration

Original Article

Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina

Romina Libster, M.D., Jimena Bugna, M.D., Silvina Coviello, M.S., Diego R. Hijano, M.D., Mariana Dunaiewsky, M.D., Natalia Reynoso, M.D., Maria L. Cavalieri, M.D., Maria C. Guglielmo, M.D., M. Soledad Areso, M.D., Tomas Gilligan, M.D., Fernanda Santucho, M.D., Graciela Cabral, M.D., Gabriela L. Gregorio, M.D., Rina Moreno, M.D., Maria I. Lutz, M.D., Alicia L. Panigasi, M.D., Liliana Saligari, M.D., Mauricio T. Caballero, M.D., Rodrigo M. Egües Almeida, M.D., Maria E. Gutierrez Meyer, M.D., Maria D. Neder, M.D., Maria C. Davenport, M.D., Maria P. Del Valle, M.D., Valeria S. Santidrian, M.D., Guillermina Mosca, M.D., Mercedes Garcia Domínguez, M.D., Liliana Alvarez, M.D., Patricia Landa, M.D., Ana Pota, M.D., Norma Boloñati, M.D., Ricardo Dalamon, M.D., Victoria I. Sanchez Mercol, M.D., Marco Espinoza, M.D., Juan Carlos Peuchot, M.D., Ariel Karolinski, M.D., Miriam Bruno, M.D., Ana Borsa, M.D., Fernando Ferrero, M.D., Ph.D., Angel Bonina, M.D., Margarita Ramonet, M.D., Lidia C. Albano, M.D., Nora Luedicke, M.D., Elias Alterman, M.D., Vilma Savy, Ph.D., Elsa Baumeister, Ph.D., James D. Chappell, M.D., Ph.D., Kathryn M. Edwards, M.D., Guillermina A. Melendi, M.D., and Fernando P. Polack, M.D.

N Engl J Med 2010; 362:45-55January 7, 2010

Abstract

Background

While the Northern Hemisphere experiences the effects of the 2009 pandemic influenza A (H1N1) virus, data from the recent influenza season in the Southern Hemisphere can provide important information on the burden of disease in children.

Methods

We conducted a retrospective case series involving children with acute infection of the lower respiratory tract or fever in whom 2009 H1N1 influenza was diagnosed on reverse-transcriptase polymerase-chain-reaction assay and who were admitted to one of six pediatric hospitals serving a catchment area of 1.2 million children. We compared rates of admission and death with those among age-matched children who had been infected with seasonal influenza strains in previous years.

Results

Between May and July 2009, a total of 251 children were hospitalized with 2009 H1N1 influenza. Rates of hospitalization were double those for seasonal influenza in 2008. Of the children who were hospitalized, 47 (19%) were admitted to an intensive care unit, 42 (17%) required mechanical ventilation, and 13 (5%) died. The overall rate of death was 1.1 per 100,000 children, as compared with 0.1 per 100,000 children for seasonal influenza in 2007. (No pediatric deaths associated with seasonal influenza were reported in 2008.) Most deaths were caused by refractory hypoxemia in infants under 1 year of age (death rate, 7.6 per 100,000).

Conclusions

Pandemic 2009 H1N1 influenza was associated with pediatric death rates that were 10 times the rates for seasonal influenza in previous years.

Media in This Article

Figure 1Distribution of Hospitalizations and Rates of Disease Severity among Children with 2009 H1N1 Influenza in Buenos Aires.
Table 1Epidemiologic Features and Preexisting Conditions in Children Hospitalized with 2009 H1N1 Influenza Alone or with Viral Coinfection.
Article

Three times in the past century, pandemic influenza viruses have circulated globally and caused increased morbidity and mortality among persons who were not generally at risk for severe seasonal influenza.1 In March 2009, a new strain of pandemic influenza A (H1N1) virus emerged in Mexico, where it caused extensive disease in young adults,2,3 and was associated with increased morbidity in the United States.4,5

The 2009 H1N1 virus spread rapidly across the Southern Hemisphere.6,7 Morbidity and mortality were particularly high in Argentina, with numbers of confirmed cases and deaths second only to those in the United States. Although seasonal influenza viruses have been associated with a high rate of hospitalization but low mortality among children, the effect and severity of 2009 H1N1 influenza in children are unknown. We studied the effect of 2009 H1N1 virus infection during the winter of 2009 in six pediatric hospitals in Buenos Aires.

Methods

Study Period and Population

The Buenos Aires metropolitan area has an estimated pediatric population (<18 years of age) of 3.8 million.8 Of these children, more than 2 million do not have private medical insurance and may be admitted for free care at public hospitals.8 We conducted a retrospective study involving patients who were hospitalized at six public pediatric facilities in Buenos Aires from May 1 to July 31, 2009. The total catchment population of these hospitals is estimated at 1.2 million children (accounting for 57% of all children eligible for care at public hospitals).8 These hospitals are the reference public institutions in their regions.

The study began during the first week in which the 2009 H1N1 virus was detected in two hospitalized children and extended through the last week in which the virus was detected in two inpatients. Eligible patients were infants under 1 year of age and children under the age of 18 years who were admitted to pediatric wards and intensive care units (ICUs) with a diagnosis of acute respiratory infection or fever (temperature, >38.3°C). All eligible children were tested for influenza viruses. Cases of 2009 H1N1 influenza were confirmed by testing nasal aspirates or combined nasal and throat swabs with the use of a real-time reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay at regional laboratories (for 66 samples) or national laboratories (for 185 samples) according to the protocol recommended by the U.S. Centers for Disease Control and Prevention (CDC).9

Testing for seasonal influenza in 2007 and 2008 was routinely performed in public hospitals in Buenos Aires for all children who were admitted with respiratory symptoms with the use of a direct immunofluorescence assay, which has a sensitivity of 78 to 81%, as compared with RT-PCR.10,11 In addition, respiratory tract specimens were tested for respiratory syncytial virus (RSV), adenovirus, and parainfluenza virus types I, II, and III by means of a direct immunofluorescence assay and culture. Microbial growth in blood cultures was assessed with the use of the BACTEC 9240 system (Becton Dickinson).

We abstracted data from medical records, using a standardized report form modeled on the case-assessment form prepared by the CDC.12 We obtained demographic, clinical, laboratory, epidemiologic, and radiologic data from a chart review. Chest radiographs were reevaluated by an independent pediatric radiologist who was not aware of the original interpretations. Hypoxemia was defined as an oxygen saturation of less than 93% while the patient was breathing ambient air.13 Nosocomial acquisition of the 2009 H1N1 virus was defined as an onset of illness more than 72 hours after hospital admission. The study was conducted as a retrospective public health analysis of deidentified data, so approval by the institutional review board at each participating institution and informed consent were not required.

Statistical Analysis

We compared the characteristics of the children who had 2009 H1N1 influenza alone with those who had viral coinfection, using Fisher's exact test or the chi-square test for covariates and the Wilcoxon rank-sum test for continuous variables. Denominators that were used to calculate proportions varied according to the number of patients with available data. Rates of hospitalization and death associated with 2009 H1N1 influenza were calculated with the use of denominators totaling the pediatric population in the total catchment area of the hospitals since 2007, as reported by the National Institute of Statistics.8 All analyses were performed with Stata software, version 10.1. A P value of less than 0.05 was considered to indicate statistical significance.

Results

Study Population

We included 251 infants and children with confirmed 2009 H1N1 influenza in the study. The median number of patients who were admitted to each hospital was 39 (range, 14 to 71). The hospitalization rate for children with 2009 H1N1 influenza was 20.9 per 100,000 children (95% confidence interval [CI], 18.4 to 23.7), as compared with 10.3 per 100,000 (95% CI, 8.4 to 12.5) for seasonal influenza during 2008.

Of the children with confirmed 2009 H1N1 influenza, 47 (19%) had a viral coinfection (Table 1Table 1Epidemiologic Features and Preexisting Conditions in Children Hospitalized with 2009 H1N1 Influenza Alone or with Viral Coinfection.); of these, 42 had a positive test for RSV. The other five children with coinfection had a positive test for either parainfluenza virus (in three children) or adenovirus (in two children). Nonpandemic seasonal influenza viruses were confirmed in six hospitalized children who were excluded from the analysis per study protocol (three children with type A [H3N2] influenza virus, two with type B influenza virus, and one with coinfection with both H3N2 and influenza B viruses). None of the children who were infected with seasonal strains required intensive care.

Hospitalizations for 2009 H1N1 influenza first occurred during the first week of May and peaked at the end of June. According to a government directive, school and social activities were suspended for 3 to 4 weeks on June 28. The number of cases declined during this period, but the timing of the directive coincided with the natural decline in the number of influenza cases seen in previous seasonal influenza epidemics.14 By the first of August, no additional children were admitted to the participating hospitals (Figure 1AFigure 1Distribution of Hospitalizations and Rates of Disease Severity among Children with 2009 H1N1 Influenza in Buenos Aires.).

The majority of admitted children (75%) were younger than 2 years of age; 60% were infants under the age of 1 year (Figure 1B). Eighty-one children (32%) had one or more preexisting conditions, including asthma, immunosuppression, chronic lung disease, neurologic disorder, and heart disease (Table 1). Among parents for whom data regarding educational background were available, 28 of 205 mothers (14%) and 24 of 186 fathers (13%) had incomplete primary education; neither parent completed primary school in 10 homes. Fifty-eight of 191 families (30%) lived in homes with more than three persons per room. Ten of 205 children (5%) had received seasonal influenza vaccine before the 2009 season. Smoking at home was frequent. Among 159 children with available information, 66 (42%) had had close contact with someone with influenza-like symptoms in the 7 days before admission.

Clinical Manifestations and Hospital Course

Two thirds of the patients with available information (156 of 236) presented more than 48 hours after the onset of symptoms. The median time to consultation (either on an outpatient basis or on hospital admission) was 4 days (range, 1 to 30). No differences were observed in the time to consultation between surviving patients and those who died.

Hospitalized children who were infected with only the 2009 H1N1 virus were older than those who were coinfected with another virus (median age, 10 months vs. 7 months; P=0.009) (Table 1 and Figure 1B). Nosocomial transmission of 2009 H1N1 influenza was observed in three patients, including a 14-year-old boy who had previously been admitted with multiple traumatic injuries and died of 2009 H1N1 influenza.

Signs and symptoms on admission included fever (in 88% of the children), cough (in 70%), rhinorrhea (in 32%), and hypoxemia (in 82%) (Table 2Table 2Clinical Signs and Symptoms, Respiratory Complications, and Results of Laboratory Tests in Children Hospitalized with 2009 H1N1 Influenza Alone or with Viral Coinfection.). Wheezing was noted in 16% of the patients, and gastrointestinal symptoms were frequent in patients who were infected only with the 2009 H1N1 virus (P=0.06 for the comparison between single infection and coinfection) (Table 2). In children who were older than 5 years of age, pain-related symptoms were infrequent (6% with odynophagia or myalgia). Three children (12, 16, and 28 months of age) presented with febrile seizures, with only one having a history of neurologic disease.

Among children with available data, oseltamivir was administered within 48 hours after the onset of symptoms in 4 of 34 children (12%) in the ICU and in 18 of 137 children (13%) in the pediatric ward. Among 194 patients with available data on the duration of therapy, 19 were treated for less than 5 days, 150 for 5 days, and 25 for 10 or more days; 118 were under 1 year of age, and only 7 of these patients received treatment within 48 hours after the onset of symptoms. Timely antiviral administration increased from 9% in early June (from June 1 to June 15) to 54% the following month (from July 1 to July 15) after specific guidelines were issued by public health authorities on June 16. However, the use of antiviral therapy did not significantly affect the risk of admission to an ICU (odds ratio for risk of admission, 0.88; 95% CI, 0.20 to 2.95; P=0.83).

Oxygen supplementation was provided to 82% of hospitalized patients for a median duration of 6 days (range, 1 to 60) (Table 2). The majority of hospitalizations were for severe hypoxemia, with 47 patients (19%) requiring admission to an ICU and 42 patients (17%) requiring mechanical ventilation. High-frequency oscillatory ventilation and extracorporeal membrane oxygenation were not available at these hospitals.

A preexisting diagnosis of asthma was significantly associated with the risk of admission to an ICU (odds ratio, 4.92; 95% CI, 1.38 to 17.33; P=0.002), whereas patients with immunosuppression associated with human immunodeficiency virus infection and those with cancer who were receiving chemotherapy were less likely to be admitted to an ICU (P=0.04).

Bacterial Complications

Among patients with 2009 H1N1 influenza, 25 had confirmed or presumptive bacterial pneumonia, with empyema developing in 4 of these children (Streptococcus pneumoniae in 1 patient, methicillin-resistant Staphylococcus aureus in 1 patient, and negative cultures in 2 patients). Pneumonia developed in five children more than 72 hours after hospitalization. Pneumothorax developed in six children (of whom four were receiving mechanical ventilation); two of the children with pneumothorax had bacterial pneumonia.

Blood cultures were positive in 10 children. The most frequent isolate was coagulase-negative staphylococcus, in four children, followed by S. pneumoniae, in two children (S. pneumoniae vaccine coverage is low in Argentina15) (Table 2). Antibiotics were administered to 143 of 204 children (70%) in pediatric wards, as compared with 43 of 47 children (91%) in ICUs (P=0.002). Eighty-two children received antibiotics on admission. Ceftriaxone and ampicillin were prescribed most frequently. Corticosteroids were administered to 20 of 47 patients (43%) in ICUs; no survival benefit from the use of corticosteroids was observed (P=0.60).

Laboratory Tests on Admission

Mean white-cell and platelet counts were within normal limits on admission (iron-deficiency anemia is often observed in this population), although 61 of 214 patients (29%) with available data had thrombocytosis (platelet count, >450,000 per cubic millimeter). Leukopenia (absolute leukocyte count, <1000 per cubic millimeter) was present in only 5 of 221 children (2%).

Radiographic Evaluation

Ninety-two chest radiographs obtained on admission in 76 patients were available for reevaluation by an independent pediatric radiologist. The most frequent radiographic diagnosis was pneumonia (78%), which was focal in 33% of the patients and multifocal in 45%. Pneumonic processes were more often observed in a single lung (in the right lung in 55% of the patients and in the left lung in 16% of the patients) than in both lungs (in 29% of the patients).

Deaths

Of 251 patients who were admitted to the hospital, 13 (5%) died, for an overall death rate of 1.1 per 100,000 children (Table 3Table 3Characteristics of Hospitalized Children with 2009 H1N1 Influenza Who Died. and Figure 1E). Twelve of the children who died had only 2009 H1N1 influenza, and one was coinfected with RSV. The median duration of illness before death was 5 days (range, 1 to 15). Three children (23%) died within 3 days after the onset of symptoms.

The death rate was highest among hospitalized infants, at 7.6 per 100,000 (Figure 1E). No deaths were identified in infants with seasonal influenza in 2007 and 2008, although in 2007 two older children died from seasonal influenza. The median age of the 13 children who died was 19 months (range, 1 month to 14.5 years). Eleven of the children (85%) were younger than 4 years of age, and 6 (46%) were infants. No association was observed between the parents' educational background or smoking status or the number of persons in the home and the risk of death. No significant differences were observed in the rates of death among the six hospitals (P=0.22).

The majority of patients died from refractory hypoxemia (62%) (Table 3). No patients who died had bacteremia; three had presumptive or confirmed bacterial pneumonia (one with sterile empyema). Nine patients (69%) had a preexisting illness that was associated with increased mortality (odds ratio, 4.87; 95% CI, 1.30 to 22.23; P=0.005), including a neurologic disorder (odds ratio, 5.62; 95% CI, 1.13 to 22.63; P=0.003) and chronic lung disease (including asthma) (odds ratio, 3.69; 95% CI, 1.03 to 13.64; P=0.02). Of the 13 patients who died, 5 were hospitalized within 48 hours after the onset of symptoms; none received timely oseltamivir. No autopsies were performed.

Discussion

In our study, we found that the hospitalization rate for 2009 H1N1 influenza among children was twice that for 2008 seasonal influenza in the same population. The rate of death was 10 times the rate associated with seasonal influenza for the same population in 2007 and 5 times the rate reported by the CDC for the U.S. pediatric population during the relatively severe 2003–2004 influenza season (0.2 deaths per 100,000 children).16 Mortality was particularly high among infants (7.6 deaths per 100,000 children), which was 10 times the U.S. infant death rate from seasonal influenza in 2003–2004.16 Notably, no deaths of infants with seasonal influenza were identified in Buenos Aires hospitals in either 2007 or 2008. Bacterial coinfection was uncommon in 2009. Most deaths were attributable to refractory hypoxemia.

Pediatric 2009 H1N1 influenza is distinguished by its severity. As is consistent with our current findings, a population-based study that was conducted in the United States showed a high rate of hospitalization for seasonal influenza among children who were under the age of 2 years, and 11% of the hospitalized children had coinfection with RSV; 72% of the cases of influenza were initially unrecognized, precluding timely antiviral treatment.17 However, only 5% of those hospitalized children were admitted to the ICU, only 22% required oxygen supplementation, and none required mechanical ventilation or died.17,18 This is in marked contrast to our findings for the current pandemic, in which 19% of the children were admitted to the ICU, 82% required oxygen, 17% required mechanical ventilation, and 5% died. In the United States, the estimated yearly number of deaths related to seasonal influenza in children under the age of 5 years is 92,19 with 153 reported deaths in 2003–2004 for children under the age of 18.16

During the pandemic season, pediatric units in Buenos Aires that provide medical care to 1.2 million children collectively reported 13 influenza-related deaths. This season was unprecedented in the number of cases, disease burden, and severity. Elective surgeries were canceled for infection-control purposes, emergency rooms and hospital wards were overwhelmed with sick children, and ICUs were forced to expand their regular facilities. Recent reports point to the severity of the upcoming pediatric influenza season in the United States.20 Hospitalized children with 2009 H1N1 influenza in the Northern Hemisphere also had high rates of preexisting illness, especially asthma and neurologic disorders.20-22

Deaths that were associated with 2009 H1N1 influenza in Buenos Aires occurred predominantly in young children. Two thirds of fatal cases were attributed to refractory hypoxemia. Bacterial coinfection was identified in few patients from cultures of blood or pleural fluid, a finding that is in agreement with recent reports.20,21 In a retrospective case series of influenza-associated deaths in the United States during the 2003–2004 influenza season, 24% of children had coinfection on the basis of cultures from multiple sites.16 In that retrospective series, mortality was highest among children under the age of 6 months, the median age among fatal cases was 3 years, and 53% of the patients who died had chronic medical conditions.16 The median duration of illness was 5 days, and 29% of patients died within 3 days after the onset of symptoms.

Some similarities exist between the above-mentioned patients in the United States and the children who were hospitalized with 2009 H1N1 influenza in Buenos Aires. In Argentina, the death rate was also highest among infants but was 10 times the rate during the 2003–2004 influenza season in the United States, and 69% of the patients who died had chronic medical conditions. Preexisting neurologic and chronic lung disorders specifically increased the odds of death. The median duration of illness in patients who died was 5 days, and 23% died within 3 days after the onset of symptoms, findings that are consistent with the CDC report.16 Factors that may have contributed to the high proportion of deaths in Buenos Aires include the rate of chronic medical conditions (69%), delayed consultation or hospital admission, and the unrecognized presentation of 2009 H1N1 influenza.17

In the United States, current recommendations for vaccination give priority to children between the ages of 6 months and 18 years.23 The results of our study support the finding that children under the age of 4 years are at markedly increased risk for severe disease. In addition, children with asthma or neurologic disorders have an increased risk of death.20-22,24

Severe illness from pandemic influenza viruses preferentially occurs in young patients who may have a preexisting, although nonprotective, immunity against the new strain or serotype.2,3,25-29 Therefore, if the severity of infection is indeed decreased by immunosuppression, cross-reactive nonprotective immunity might contribute to pathogenesis.

At the peak of the epidemic, the Argentine government closed schools, suspended community gatherings, encouraged social distancing, and conducted an intense awareness campaign. Empirical therapy with oseltamivir for patients with influenza-like symptoms was also recommended for high-risk and hospitalized children.30 The number of cases subsided soon thereafter. Yet seasonal influenza in 2007 followed a very similar pattern, complicating the interpretation of the specific effect of these interventions. A similar campaign nevertheless seemed to be successful in Mexico.31

There are several limitations of our study. First, experiences may vary in scope and magnitude in other countries. Second, the detection of influenza in 2007–2008 was performed by means of a direct immunofluorescence assay, which underestimated the number of infections, as compared with the RT-PCR assay, for 2009 H1N1 influenza. Third, clinical evaluation and data recording were not standardized, and observations may have differed among hospitals or health care providers.

Pediatric infection with the pandemic influenza virus is associated with substantial mortality. Important tools for minimizing the severity of infection include educating the general population and health care providers in order to promote early case recognition, considering early empirical antiviral therapy for children with 2009 H1N1 influenza–like illness who have preexisting neurologic disorders or chronic lung diseases, and promoting the availability of the H1N1 vaccine.

Supported by the Fundación INFANT 2008 Fundraising Campaign and the Director's Challenge Award from the National Institute of Environmental Health Sciences (to Dr. Polack); the Carrillo–Oñativia Scholarship, Argentine National Ministry of Health (to Dr. Bugna); and an Early Career Thrasher Award from the Thrasher Research Fund and the Fogarty International Center Clinical Research Fellow Program at Vanderbilt University (to Dr. Melendi).

No potential conflict of interest relevant to this article was reported.

Drs. Libster and Bugna and Ms. Coviello contributed equally to this article.

This article (10.1056/NEJMoa0907673) was published on December 23, 2009, at NEJM.org.

We thank G. Fernandez Gago, M.V. Corradi, M. Carbonari, F. Zamperetti, B. Tomas, N. Telo Broglio, M. Morete, C. Zea, H. Trevisán, D. Bergna, C. Cipolla, J. Pujol, E. Segal, E. Lancioni, and A.S. Fallesen at Hospital de Niños Sor Maria Ludovica; V. Celavegna, C. Ferrario, M.J. Rial, and E. Luzi at Hospital de Niños Pedro de Elizalde; V. Schuster, M. Beccaria, L. Lopez, and L. Serralta at Hospital Durand; N. Alabart, L.V. Politanski, M. Sarli, and C. Lapera at Hospital Posadas; R. Pena at Hospital Materno Infantil Dr. Carlos Gianantonio; and V. Molina at Dr. Carlos G. Malbrán Institute, all in Buenos Aires, for their contributions.

Source Information

The authors' affiliations are listed in the Appendix.

Address reprint requests to Dr. Polack at Vanderbilt Vaccine Center, Department of Pediatrics, Vanderbilt University, 1161 21st Ave., D-7235 MCN, Nashville, TN 37232, or at .

Appendix

The authors' affiliations are as follows: Fundación INFANT (R.L., J.B., S.C., M.E., E.A., G.A.M., F.P.P.); Instituto de Desarrollo e Investigaciones Pediatricas, Hospital de Ninos Sor Ludovica de La Plata (D.R.H.); Programa INFANT, Ministerio de Ciencia, Técnica e Innovación Productiva (D.R.H., M.D., N.R., M.L.C., M.C.G., M.S.A., M.T.C., R.M.E.A., M.E.G.M., G.M., V.I.S.M.); Hospital de Niños Pedro de Elizalde (M.D., M.C.G., M.D.N., M.C.D., M.P.D.V., V.S.S., F.F., A.B.); Hospital Materno Infantil Dr. Carlos Gianantonio (N.R., G.M., M.G.D., N.L.); Hospital Eva Peron (M.L.C., M.S.A., V.I.S.M., J.C.P.); Hospital Durand (T.G., F.S., L.A., P.L., A.P., N.B., R.D., A.K., M.B.); Hospital Posadas (G.C., G.L.G., R.M., M.I.L., A.L.P., L.S., M.R., L.C.A.); Hospital de Niños Sor Maria Ludovica (M.T.C., R.M.E.A., M.E.G.M., A.B.); and Dr. Carlos G. Malbrán Institute (V.S., E.B.) — all in Buenos Aires; and the Departments of Pediatrics (R.L., K.M.E., G.A.M., F.P.P.) and Pathology (J.D.C.), Vanderbilt University, Nashville.

References

References

  1. 1

    Simonsen L, Olson DR, Viboud C, et al. Pandemic influenza and mortality: past evidence and projection for the future. In: Knobler SL, Mack A, Mahmoud A, Lemon SM, eds. The threat of pandemic influenza: are we ready? Washington, DC: National Academies Press, 2005:89-114.

  2. 2

    Chowell G, Bertozzi SM, Colchero MA, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-679
    Full Text | Web of Science | Medline

  3. 3

    Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-688
    Full Text | Web of Science | Medline

  4. 4

    Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-458
    CrossRef | Web of Science | Medline

  5. 5

    Preliminary information important for understanding the evolving situation: pandemic (H1N1) 2009 briefing note 4, July 24, 2009. (Accessed December 10, 2009, at http://www.cdc.gov/H1N1flu/updates/us.)

  6. 6

    Geographic spread of influenza activity. (Accessed December 10, 2009, at http://www.who.int/csr/don/Global_geographicSpreadH1N1A_week31.png.)

  7. 7

    Cases of human infection with pandemic (H1N1) 2009 virus in the Americas by epidemiological week. (Accessed December 10, 2009, at http://new.paho.org/hq/images/atlas/en/atlas.html.)

  8. 8

    Resultados provinciales del Censo 2001: información seleccionada. (Accessed December 10, 2009, at http://www.indec.gov.ar/webcenso/provincias_2/provincias.asp.)

  9. 9

    H1N1 flu: clinical and public health guidance: vaccination guidance for state, local, tribal and territorial health officials. (Accessed December 10, 2009, at http://www.cdc.gov/H1N1flu/casedef.htm.)

  10. 10

    Freymuth F, Vabret A, Cuvillon-Nimal D, et al. Comparison of multiplex PCR assays and conventional techniques for the diagnosis of respiratory virus infection in children admitted to hospital with an acute respiratory illness. J Med Virol 2006;78:1498-1504
    CrossRef | Web of Science | Medline

  11. 11

    Rahman M, Vandermause MF, Kieke BA, Belongia EA. Performance of Binax NOW Flu A and B direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. Diagn Microbiol Infect Dis 2008;62:162-166
    CrossRef | Web of Science | Medline

  12. 12

    Swine influenza case report form. (Accessed December 10, 2009, at http://www.cdc.gov/h1n1flu/clinicians/pdf/updated-case-report-form_05012009.pdf.)

  13. 13

    Laham FR, Israele V, Casellas JM, et al. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 2004;189:2047-2056
    CrossRef | Web of Science | Medline

  14. 14

    Situación influenza pandémica H1N1: Sept. 1, 2009. (Accessed December 10, 2009, at http://www.msal.gov.ar/htm/site/pdf/Epi-01-09.pdf.)

  15. 15

    Sociedad Argentina de Pediatría. Calendario de vacunación. (Accessed December 10, 2009, at http://www.sap.org.ar/prof-calend-vacu.php.)

  16. 16

    Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005;353:2559-2567
    Full Text | Web of Science | Medline

  17. 17

    Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006;355:31-40
    Full Text | Web of Science | Medline

  18. 18

    Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-231
    Full Text | Web of Science | Medline

  19. 19

    Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186
    CrossRef | Web of Science | Medline

  20. 20

    Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944
    Full Text | Web of Science | Medline

  21. 21

    Hackett S, Hill L, Patel J, et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 2009;374:605-605
    CrossRef | Web of Science | Medline

  22. 22

    Lister P, Reynolds F, Parlsow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009;374:605-607
    CrossRef | Web of Science | Medline

  23. 23

    2009 H1N1 vaccination recommendations. (Accessed December 10, 2009, at http://www.cdc.gov/h1n1flu/vaccination/acip.htm.)

  24. 24

    Martinez FD. Links between pediatric and adult asthma. J Allergy Clin Immunol. 2001;107:Suppl:S449-S455.

  25. 25

    Andreasen V, Vivoud C, Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008;197:270-278
    CrossRef | Web of Science | Medline

  26. 26

    Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998;178:53-60
    Web of Science | Medline

  27. 27

    Olson DR, Simonsen L, Edelson PJ, Morse SS. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci U S A 2005;102:11059-11063
    CrossRef | Web of Science | Medline

  28. 28

    Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-52.

  29. 29

    Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:521-524
    Medline

  30. 30

    Ministerio de Salud. Inicio de la pandemia de influenza 2009. (Accessed December 10, 2009, at http://www.msal.gov.ar/htm/site/pdf/alerta-epidemiologico-8.pdf.)

  31. 31

    Cordova-Villalobos JA, Sarti E, Arzoz-Padres J, Manuell-Lee G, Mendez JR, Kuri-Morales P. The influenza A(H1N1) epidemic in Mexico: lessons learned. Health Res Policy Syst 2009;7:21-21
    CrossRef | Medline

Citing Articles (92)

Citing Articles

  1. 1

    Cynthia J. Yen, Janice K. Louie, Robert Schechter. (2012) Infants Hospitalized in Intensive Care Units With 2009 H1N1 Influenza Infection, California, 2009–2010. The Pediatric Infectious Disease Journal 31:3, e52-e55
    CrossRef

  2. 2

    Shikha Garg, Alicia M. Fry, Monica Patton, Anthony E. Fiore, Lyn Finelli. (2012) Antiviral Treatment of Influenza in Children. The Pediatric Infectious Disease Journal 31:2, e43-e51
    CrossRef

  3. 3

    , Pierre-Alex Crisinel, Constance Barazzone, Laurent Kaiser, Arnaud G. L’Huillier, Jean Taguebue, Noémie Wagner, Cristina Delcò, Claire-Anne Siegrist, Klara M. Posfay-Barbe. (2012) Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patients. European Journal of Pediatrics 171:1, 159-166
    CrossRef

  4. 4

    Patrick M Smit, Karlien M Bongers, Rosalie JL Kuiper, Ines A von Rosenstiel, Paul HM Smits, Dees PM Brandjes. (2012) Characterization of 2009 H1N1 pandemic influenza in a population of Dutch children with influenza-like signs and symptoms. Acta Paediatrica 101:1, 67-72
    CrossRef

  5. 5

    Niranjan Kissoon. (2012) Pediatric mass critical care in a pandemic. Pediatric Critical Care Medicine 13:1, 106-107
    CrossRef

  6. 6

    Tanl Kendirli, Demet Demirkol, Dinçer Yldzdas, Ayse Berna Anl, Nazik Asloğlu, Bülent Karapnar, Nilgün Erkek, Esra Sevketoğlu, Oğuz Dursun, Ali Ertuğ Arslanköylü, Benan Bayrakç, Mehmet Bosnak, Tolga Köroğlu, Özgür Özden Horoz, Agop Çtak, Selman Kesici, Can Ates, Metin Karaböcüoğlu, Erdal I[Combining Dot Above]nce. (2012) Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey*. Pediatric Critical Care Medicine 13:1, e11-e17
    CrossRef

  7. 7

    Caroline B. Long, Irene Ramos, Deepa Rastogi, Deepa Manwani, Ginger Janow, Marcela Del Rio, Marguerite Mayers, Betsy C. Herold, Ana Fernandez-Sesma, Rebecca Pellett Madan. (2012) Humoral and Cell-Mediated Immune Responses to Monovalent 2009 Influenza A/H1N1 and Seasonal Trivalent Influenza Vaccines in High-Risk Children. The Journal of Pediatrics 160:1, 74-81
    CrossRef

  8. 8

    Elizabeth J Elliott, Yvonne A Zurynski, Tony Walls, Bruce Whitehead, Robin Gilmour, Robert Booy, . (2011) Novel inpatient surveillance in tertiary paediatric hospitals in New South Wales illustrates impact of first-wave pandemic influenza A H1N1 (2009) and informs future health service planning. Journal of Paediatrics and Child Healthno-no
    CrossRef

  9. 9

    Ergin Çiftçi, Nilden Tuygun, Halil Özdemir, Hasan Tezer, Gülnar Şensoy, İlker Devrim, Nazan Dalgiç, Ateş Kara, Mehmet Turgut, Anil Tapisiz, Melike Keser, Solmaz Çelebi, Nuri Bayram, Emine Kocabaş, Ener Çağri Dinleyici, Metehan Özen, Ahmet Soysal, Necdet Kuyucu, Gönül Tanir, Elif Çelikel, Nurşen Belet, Gültaç Evren, Didem Büyüktaş Aytaç, Ali Bülent Cengiz, Perihan Yasemen Canöz, Okşan Derinöz, Erdal İnce, Mustafa Hacimustafaoğlu, Murat Anil, Özlem Özgür, Canan Kuzdan, Eda Özaydin, Nazik Aşilioğlu, Ceyhun Dizdarer, Mehmet Ceyhan, Ibrahim Hakan Bucak, Tanil Kendirli, Halil İbrahim Yakut, Tunç Fişgin, Nurettin Ünal, Hakan Altindağ, Ayşe Ayzit Kilinç, Seray Umut Zöhre, Atilla Halil Elhan, Ülker Doğru. (2011) Clinical and epidemiological features of Turkish children with 2009 pandemic influenza A (H1N1) infection: Experience from multiple tertiary paediatric centres in Turkey. Scandinavian Journal of Infectious Diseases 43:11-12, 923-929
    CrossRef

  10. 10

    David J. Jackson, Annemarie Sykes, Patrick Mallia, Sebastian L. Johnston. (2011) Asthma exacerbations: Origin, effect, and prevention. Journal of Allergy and Clinical Immunology 128:6, 1165-1174
    CrossRef

  11. 11

    Jane Faith Kapustin. (2011) Influenza 2011-2012. The Nurse Practitioner 36:11, 48-52
    CrossRef

  12. 12

    Jason W. Custer, Christopher M. Watson, Joe Dwyer, David W. Kaczka, Brett A. Simon, R. Blaine Easley. (2011) Critical evaluation of emergency stockpile ventilators in an in vitro model of pediatric lung injury. Pediatric Critical Care Medicine 12:6, e357-e361
    CrossRef

  13. 13

    Eduardo Lopez-Medina, Monica I. Ardura, Jane D. Siegel, Evangeline Brock, Pablo J. Sánchez. (2011) 2009 Influenza A in Infants Hospitalized at Younger than 6 Months. The Journal of Pediatrics
    CrossRef

  14. 14

    Wanatpreeya Phongsamart, Virat Sirisanthana, Orasri Wittawatmongkol, Alan Maleesatharn, Tavitiya Sudjaritruk, Pimpannada Chearskul, Linda Aurpibul, Thira Sirisanthana, Kulkanya Chokephaibulkit. (2011) Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Vaccine 29:47, 8705-8711
    CrossRef

  15. 15

    A. Karlstrom, S. M. Heston, K. L. Boyd, E. I. Tuomanen, J. A. McCullers. (2011) Toll-Like Receptor 2 Mediates Fatal Immunopathology in Mice During Treatment of Secondary Pneumococcal Pneumonia Following Influenza. Journal of Infectious Diseases 204:9, 1358-1366
    CrossRef

  16. 16

    Daniel E. Dulek, R. Stokes Peebles. (2011) Viruses and asthma. Biochimica et Biophysica Acta (BBA) - General Subjects 1810:11, 1080-1090
    CrossRef

  17. 17

    Teresa del Rosal, Fernando Baquero-Artigao, Cristina Calvo, María J. Mellado, Juan C. Molina, María del Mar Santos, María J. Cilleruelo, Mercedes Bueno, Pilar Storch de Gracia, Covadonga Terol, Miguel Á. Roa, Roi Piñeiro, Milagros García López-Hortelano, María L. García-García, Sonia Rodríguez, María Penín, Alejandro Zarauza, Francisco Alvarado, Ana de Blas, Enrique Otheo, Alfonso Rodríguez, María L. Herreros, Alfredo Tagarro, Luis Grande, José T. Ramos, Irene Maté, Cristina Muñoz, Miguel Á. Zafra, María P. Romero-Gómez, Elia Pérez-Fernández, Alberto Delgado, Inmaculada Casas, María E. Cabezas. (2011) Pandemic H1N1 influenza-associated hospitalizations in children in Madrid, Spain. Influenza and Other Respiratory Viruses 5:6, e544-e551
    CrossRef

  18. 18

    Aarti Avinash Kinikar, Rajesh K. Kulkarni, Chhaya T. Valvi, Vidya Mave, Nikhil Gupte, Sandhya Khadse, Renu Bhardwaj, Anju Kagal, Shaila Puranik, Amita Gupta, Robert Bollinger, Arun Jamkar. (2011) Predictors of Mortality in Hospitalized Children with Pandemic H1N1 Influenza 2009 in Pune, India. The Indian Journal of Pediatrics
    CrossRef

  19. 19

    Norio Sugaya, Masayoshi Shinjoh, Keiko Mitamura, Takao Takahashi. (2011) Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children. Journal of Infection 63:4, 288-294
    CrossRef

  20. 20

    Jung Sook Yeom, Ji Sook Park, Ji-Hyun Seo, Eun Sil Park, Jae-Young Lim, Chan-Hoo Park, Hyang-Ok Woo, Hee-Shang Youn, Jae Min Cho. (2011) Factors associated with hypoxemia in children infected with pandemic H1N1 2009 influenza virus. Pediatrics International 53:5, 622-625
    CrossRef

  21. 21

    Kristen E. Metzger, Stephanie R. Black, Roderick C. Jones, Shaun R. Nelson, Ari Robicsek, Gordon M. Trenholme, Mary Alice Lavin, Stephen G. Weber, Sylvia Garcia-Houchins, Emily Landon, Jorge P. Parada, Susan I. Gerber. (2011) Identification, Management, and Clinical Characteristics of Hospitalized Patients with Influenza-Like Illness during the 2009 H1N1 Influenza Pandemic, Cook County, Illinois. Infection Control and Hospital Epidemiology 32:10, 998-1002
    CrossRef

  22. 22

    Marie A. Perio, Douglas M. Wiegand, Stefanie M. Evans. (2011) Low Influenza Vaccination Rates Among Child Care Workers in the United States: Assessing Knowledge, Attitudes, and Behaviors. Journal of Community Health
    CrossRef

  23. 23

    Ville Peltola, Tamara Teros-Jaakkola, Maris Rulli, Laura Toivonen, Eeva Broberg, Matti Waris, Jussi Mertsola. (2011) Pandemic influenza A (H1N1) virus in households with young children. Influenza and Other Respiratory Virusesno-no
    CrossRef

  24. 24

    Hongxia Shao, Jianqiang Ye, Amy L. Vincent, Nicole Edworthy, Andrea Ferrero, Aijian Qin, Daniel R. Perez. (2011) A novel monoclonal antibody effective against lethal challenge with swine-lineage and 2009 pandemic H1N1 influenza viruses in mice. Virology 417:2, 379-384
    CrossRef

  25. 25

    A. Pierangeli, C. Scagnolari, C. Selvaggi, K. Monteleone, S. Verzaro, R. Nenna, G. Cangiano, C. Moretti, P. Papoff, G. Antonelli, F. Midulla. (2011) Virological and clinical characterization of respiratory infections in children attending an emergency department during the first autumn-winter circulation of pandemic A (H1N1) 2009 influenza virus. Clinical Microbiology and Infectionno-no
    CrossRef

  26. 26

    Raymond Roberge. (2011) Facemask Use by Children During Infectious Disease Outbreaks. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 9:3, 225-231
    CrossRef

  27. 27

    Bernward Zeller, Marit Hellebostad. (2011) H1N1 infection in children with haematological and oncological diseases in Norway. Acta Paediatrica 100:8, 1134-1137
    CrossRef

  28. 28

    Luis Moral, Nuria Marco, Teresa Toral, María Jesús Fuentes, Laura Fuentes, Lucía Lillo. (2011) Burden of Severe 2009 Pandemic Influenza A (H1N1) Infection in Children in Southeast Spain. Enfermedades Infecciosas y Microbiología Clínica 29:7, 497-501
    CrossRef

  29. 29

    Emilio Aguirre, Jesse Papenburg, Manale Ouakki, Patricia S. Fontela, Chantal Guimont, Gaston De Serres, Guy Boivin. (2011) Comparison of Pandemic and Seasonal Influenza in the Pediatric Emergency Department. The Pediatric Infectious Disease Journal 30:8, 633-639
    CrossRef

  30. 30

    M. Coppola, A. Porto, D. Santo, S. Fronzo, R. Grassi, A. Rotondo. (2011) Influenza A virus: radiological and clinical findings of patients hospitalised for pandemic H1N1 influenza. La radiologia medica 116:5, 706-719
    CrossRef

  31. 31

    Gal Dubnov-Raz, Raz Somech, Yaniv Warschawski, Gilad Eisenberg, Yoram Bujanover. (2011) Clinical characteristics of children with 2009 pandemic H1N1 influenza virus infections. Pediatrics International 53:4, 426-430
    CrossRef

  32. 32

    Rodica Gilca, Gaston De Serres, Nicole Boulianne, Najwa Ouhoummane, Jesse Papenburg, Monique Douville-Fradet, Élise Fortin, Marc Dionne, Guy Boivin, Danuta M. Skowronski. (2011) Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza and Other Respiratory Viruses 5:4, 247-255
    CrossRef

  33. 33

    E. Lera Carballo, N.T. Wörner, M. Sancosmed Ron, A. Fàbregas Martori, A. Casquero Cossío, R. Cebrián Rubio. (2011) Impacto del virus de la gripe A (H1N1) 2009 en un servicio de urgencias de un hospital de tercer nivel. Anales de Pediatría 75:1, 13-20
    CrossRef

  34. 34

    M. Vilà de Muga, N. Torre Monmany, S. Asensio Carretero, F.J. Travería Casanovas, A. Martínez Mejías, M.T. Coll Sibina, C. Luaces Cubells. (2011) Características clínicas de la gripe A H1N1 2009: estudio multicéntrico. Anales de Pediatría 75:1, 6-12
    CrossRef

  35. 35

    Jérôme Mattéi, Georges Teyssier, Vincent Pichot, Jean-Claude Barthélémy, Emilie Achour, Sylvie Pillet, Thomas Bourlet, Hugues Patural. (2011) Autonomic dysfunction in 2009 pandemic influenza A (H1N1) virus-related infection: A pediatric comparative study. Autonomic Neuroscience 162:1-2, 77-83
    CrossRef

  36. 36

    Dominic E. Dwyer. (2011) Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: The INSIGHT FLU 002 and FLU 003 studies. Vaccine 29, B56-B62
    CrossRef

  37. 37

    Andrew Fretzayas, Maria Moustaki, Doxa Kotzia, Polyxeni Nicolaidou. (2011) Rash, an uncommon but existing feature of H1N1 influenza among children. Influenza and Other Respiratory Viruses 5:4, 223-224
    CrossRef

  38. 38

    Cristian Launes, Juan-José García-García, Iolanda Jordán, Aina Martínez-Planas, Laura Selva, Carmen Muñoz-Almagro. (2011) 2009 Influenza A H1N1 Infections. The Pediatric Infectious Disease Journal 30:7, 622-625
    CrossRef

  39. 39

    Hassen Damak, Kamilia Chtara, Mabrouk Bahloul, Hatem Kallel, Anis Chaari, Hichem Ksibi, Adel Chaari, Hedi Chelly, Noureddine Rekik, Chokri Ben Hamida, Mounir Bouaziz. (2011) Clinical features, complications and mortality in critically ill patients with 2009 influenza A(H1N1) in Sfax,Tunisia. Influenza and Other Respiratory Viruses 5:4, 230-240
    CrossRef

  40. 40

    Dinçer Yıldızdaş, Tanıl Kendirli, Ali Ertuğ Arslanköylü, Özden Özgür Horoz, Faruk İncecik, Erdal İnce, Ergin Çiftçi. (2011) Neurological complications of pandemic influenza (H1N1) in children. European Journal of Pediatrics 170:6, 779-788
    CrossRef

  41. 41

    Munish Gupta, DeWayne M. Pursley. (2011) A survey of infection control practices for influenza in mother and newborn units in US hospitals. American Journal of Obstetrics and Gynecology 204:6, S77-S83
    CrossRef

  42. 42

    Naoki Kawai, Hideyuki Ikematsu, Osame Tanaka, Shinro Matsuura, Tetsunari Maeda, Satoshi Yamauchi, Nobuo Hirotsu, Mika Nishimura, Norio Iwaki, Seizaburo Kashiwagi. (2011) Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons. Journal of Infection and Chemotherapy 17:3, 375-381
    CrossRef

  43. 43

    J Martic, N Savic, P Minic, S Pasic, J Nedeljkovic, B Jankovic. (2011) Novel H1N1 influenza in neonates: from mild to fatal disease. Journal of Perinatology 31:6, 446-448
    CrossRef

  44. 44

    S. Boxhammer, R. Lepler, H. Lenhartz, B. Püst, P.H. Höger. (2011) Influenza A/H1N1-2009 bei Kindern und Jugendlichen in Hamburg. Monatsschrift Kinderheilkunde 159:6, 560-564
    CrossRef

  45. 45

    Su Young Kim, Jeung Sook Kim, Chan Sup Park. (2011) Various computed tomography findings of 2009 H1N1 influenza in 17 patients with relatively mild illness. Japanese Journal of Radiology 29:5, 301-306
    CrossRef

  46. 46

    Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith, Viswanathan Niranjan. (2011) Safety profile of oseltamivir during the 2009 influenza pandemic. Pharmacoepidemiology and Drug Safety 20:5, 532-543
    CrossRef

  47. 47

    Justin L. Lockman, David G. Nichols. (2011) Planning for the next influenza pandemic: What should we expect?*. Pediatric Critical Care Medicine 12:3, 371-372
    CrossRef

  48. 48

    Jorge S. Sasbón, Mónica A. Centeno, Mauro D. García, Nancy B. Boada, Bettina E. Lattini, Eduardo A. Motto, Marcela A. Zuázaga, Viviana V. Acebedo, Martín E. Truszkowski, Silvia Filippini. (2011) Influenza A (pH1N1) infection in children admitted to a pediatric intensive care unit: Differences with other respiratory viruses*. Pediatric Critical Care Medicine 12:3, e136-e140
    CrossRef

  49. 49

    Rashmi Ranjan Das, Abdus Sami, Rakesh Lodha, Richa Jain, S. Broor, S. Kaushik, B. B. Singh, M. Ahmed, Rachna Seth, Sushil K. Kabra. (2011) Clinical profile and outcome of swine flu in Indian children. Indian Pediatrics 48:5, 373-378
    CrossRef

  50. 50

    M. Bué, J. Chevallier, P. Pigeon Kherchiche. (2011) Étude clinique d’une cohorte de 94 enfants atteints de la grippe A(H1N1)v à l’île de La Réunion. Bulletin de la Société de pathologie exotique 104:2, 135-141
    CrossRef

  51. 51

    D. Viasus, J. R. Paño-Pardo, J. Pachón, A. Campins, F. López-Medrano, A. Villoslada, M. C. Fariñas, A. Moreno, J. Rodríguez-Baño, J. A. Oteo, J. Martínez-Montauti, J. Torre-Cisneros, F. Segura, F. Gudiol, J. Carratalà, . (2011) Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clinical Microbiology and Infection 17:5, 738-746
    CrossRef

  52. 52

    Gulam Khandaker, Alexa Dierig, Harunor Rashid, Catherine King, Leon Heron, Robert Booy. (2011) Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza and Other Respiratory Viruses 5:3, 148-156
    CrossRef

  53. 53

    Enrique Piacentini, Baltasar Sánchez, Vanessa Arauzo, Esther Calbo, Eva Cuchi, Juan Manuel Nava. (2011) Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study. Journal of Critical Care 26:2, 201-205
    CrossRef

  54. 54

    Mortada H.F. El-Shabrawi, Hafez M. Bazaraa, Hanan Zekri, Hanaa I. Rady. (2011) Fatal acute myocarditis and fulminant hepatic failure in an infant with pandemic human influenza A, H1N1 (2009) virus infection. Journal of Advanced Research 2:2, 191-194
    CrossRef

  55. 55

    B. D. Gupta, A. Purohit. (2011) A Clinical Study of Hospitalized H1N1 Infected Children in Western Rajasthan. Journal of Tropical Pediatrics 57:2, 87-90
    CrossRef

  56. 56

    Erica R. Gross, Jeffrey W. Gander, Ari Reichstein, Robert A Cowles, Charles J. H. Stolar, William Middlesworth. (2011) Fulminant pH1N1-09 influenza-associated myocarditis in pediatric patients. Pediatric Critical Care Medicine 12:2, e99-e101
    CrossRef

  57. 57

    Esther Lera, Núria T.Wörner, Mónica Sancosmed, Anna Fàbregas, Alejandro Casquero, Susana Melendo, Mar Miserachs, Teresa Tórtola, Astrid Borrego, Magda Campins, Fernando Moraga, Concepció Figueras, Rocío Cebrián. (2011) Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital. European Journal of Pediatrics 170:3, 371-378
    CrossRef

  58. 58

    Lior Goldberg, David Greenberg, Itay Zelcer, Leonel Slanovic, Yonat Shemer-Avni, Ronit Nativ, Avraham Borer, Gabriel Hodik, Michael Sherf, Matitiahu Lifshitz, Eugene Leibovitz. (2011) EPIDEMIOLOGIC, CLINICAL, LABORATORY, AND THERAPEUTIC CHARACTERISTICS OF INFLUENZA A/H1N1 IN MOSLEM BEDOUIN AND JEWISH CHILDREN HOSPITALIZED IN SOUTHERN ISRAEL DURING 2009. The Pediatric Infectious Disease Journal1
    CrossRef

  59. 59

    Avinash K. Shetty, Gregory A. Ross, Thomas Pranikoff, Larissa V. Gubareva, Catherine Sechrist, Derek M. Guirand, Jon Abramson, Jen-Jar Lin. (2011) Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient. Pediatric Transplantationno-no
    CrossRef

  60. 60

    H. Yu, Z. Feng, T. M. Uyeki, Q. Liao, L. Zhou, L. Feng, M. Ye, N. Xiang, Y. Huai, Y. Yuan, H. Jiang, Y. Zheng, P. Gargiullo, Z. Peng, Y. Feng, J. Zheng, C. Xu, Y. Zhang, Y. Shu, Z. Gao, W. Yang, Y. Wang. (2011) Risk Factors for Severe Illness with 2009 Pandemic Influenza A (H1N1) Virus Infection in China. Clinical Infectious Diseases 52:4, 457-465
    CrossRef

  61. 61

    Antoni Noguera-Julian, Ana C. Provens, Pere Soler-Palacín, Maria Espiau, Antonio Mur, María Méndez, Clàudia Fortuny. (2011) PANDEMIC INFLUENZA A (2009 H1N1) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CATALAN CHILDREN. The Pediatric Infectious Disease Journal 30:2, 173-175
    CrossRef

  62. 62

    Elise Launay, Philippe Ovetchkine, Maude Saint-Jean, Léna Coïc, Thierry Ducruet, Hugues Charest, Nadia Desmarais, Valérie Lamarre, Bruce Tapiéro. (2011) Novel influenza A (H1N1): clinical features of pediatric hospitalizations in two successive waves. International Journal of Infectious Diseases 15:2, e122-e130
    CrossRef

  63. 63

    Valeria Trivellin, Vera Gandini, Luigi Nespoli. (2011) Low adherence to influenza vaccination campaigns: is the H1N1 virus pandemic to be blamed?. Italian Journal of Pediatrics 37:1, 54
    CrossRef

  64. 64

    Eun Lee, Ju-Hee Seo, Hyung-Young Kim, Shin Na, Sung-Han Kim, Ji-Won Kwon, Byoung-Ju Kim, Soo-Jong Hong. (2011) Clinical characteristics and outcomes among pediatric patients hospitalized with pandemic influenza A/H1N1 2009 infection. Korean Journal of Pediatrics 54:8, 329
    CrossRef

  65. 65

    C. M. Cox, L. Blanton, R. Dhara, L. Brammer, L. Finelli. (2011) 2009 Pandemic Influenza A (H1N1) Deaths among Children--United States, 2009-2010. Clinical Infectious Diseases 52:Supplement 1, S69-S74
    CrossRef

  66. 66

    Karina T Timenetsky, Silvia HCT Aquino, Cilene Saghabi, Corinne Taniguchi, Claudia V Silvia, Luci Correa, Alexandre R Marra, Raquel AC Eid, Oscar FP dos Santos. (2011) High success and low mortality rates with non-invasive ventilation in influenza A H1N1 patients in a tertiary hospital. BMC Research Notes 4:1, 375
    CrossRef

  67. 67

    Sophie Blumental, Elisabeth Huisman, Marie-Coralie Cornet, Christine Ferreiro, Iris De Schutter, Marijke Reynders, Ingrid Wybo, Benoît Kabamba-Mukadi, Ruth Armano, Dominique Hermans, Marie-Cécile Nassogne, Bhavna Mahadeb, Christine Fonteyne, Gerlant Van Berlaer, Jack Levy, Didier Moulin, Anne Vergison, Anne Malfroot, Philippe Lepage. (2011) Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey. BMC Infectious Diseases 11:1, 313
    CrossRef

  68. 68

    Toshihiko Mori, Mayuko Morii, Kojiro Terada, Yoshimasa Wada, Yuki Kuroiwa, Tomoyuki Hotsubo, Shigeto Fuse, Seiko Nishioka, Takeshi Nishioka, Hiroyuki Tsutsumi. (2011) Clinical characteristics and computed tomography findings in children with 2009 pandemic influenza A (H1N1) viral pneumonia. Scandinavian Journal of Infectious Diseases 43:1, 47-54
    CrossRef

  69. 69

    Howard Trachtman, Christine Sethna, Robyn Epstein, Marise D’Souza, Lorry G. Rubin, Christine C. Ginocchio. (2011) Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection. Pediatric Nephrology 26:1, 145-146
    CrossRef

  70. 70

    Won Sup Oh, Seung-Joon Lee, Chang-Seop Lee, Ji-An Hur, Ae-Chung Hur, Yoon Seon Park, Sang-Taek Heo, In-Gyu Bae, Sang Won Park, Eu Suk Kim, Hong Bin Kim, Kyoung-Ho Song, Kkot Sil Lee, Sang-Rok Lee, Joon Sup Yeom, Su Jin Lee, Baek-Nam Kim, Yee Gyung Kwak, Jae Hoon Lee, Yong Keun Kim, Hyo Youl Kim, Nam Joong Kim, Myoung-don Oh. (2011) A Prediction Rule to Identify Severe Cases among Adult Patients Hospitalized with Pandemic Influenza A (H1N1) 2009. Journal of Korean Medical Science 26:4, 499
    CrossRef

  71. 71

    Carrye Cost, Evangeline Brock, Beverley Adams-Huet, Jane D. Siegel, Monica I. Ardura. (2011) 2009 pandemic influenza a (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatric Blood & Cancer 56:1, 127-133
    CrossRef

  72. 72

    Ji Eun Kim, Siegfried Bauer, Kyong Suk La, Kee Hyoung Lee, Ji Tae Choung, Kyoung Ho Roh, Chang Kyu Lee, Young Yoo. (2011) CD4+/CD8+ T lymphocytes imbalance in children with severe 2009 pandemic influenza A (H1N1) pneumonia. Korean Journal of Pediatrics 54:5, 207
    CrossRef

  73. 73

    Liviana Da Dalt, Chiara Chillemi, Maria Cavicchiolo, Silvia Bressan, Arianna Calistri, Giorgio Palù, Giorgio Perilongo. (2011) Pandemic influenza A (H1N1v) infection in pediatric population: a multicenter study in a North-East area of Italy. Italian Journal of Pediatrics 37:1, 24
    CrossRef

  74. 74

    Libster, Romina, Coviello, Silvina, , Cavalieri, Maria L., , Morosi, Adriana, , Alabart, Nora, , Alvarez, Liliana, , Ferrero, Fernando, , Edwards, Kathryn M., Polack, Fernando P., . (2010) Pediatric Hospitalizations Due to Influenza in 2010 in Argentina. New England Journal of Medicine 363:25, 2472-2473
    Full Text

  75. 75

    Carmelina Calitri, Clara Gabiano, Silvia Garazzino, Michele Pinon, Marisa Zoppo, Margherita Cuozzo, Carlo Scolfaro, Pier-Angelo Tovo. (2010) Clinical features of hospitalised children with 2009 H1N1 influenza virus infection. European Journal of Pediatrics 169:12, 1511-1515
    CrossRef

  76. 76

    Nabihah Sachedina, Liam J Donaldson. (2010) Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. The Lancet 376:9755, 1846-1852
    CrossRef

  77. 77

    David Isaacs. (2010) Lessons from the swine flu: Pandemic, panic and/or pandemonium?. Journal of Paediatrics and Child Health 46:11, 623-626
    CrossRef

  78. 78

    Fernando Lovato-Salas, Lorena Matienzo-Serment, César Monjarás-Ávila, Elizabeth E. Godoy-Lozano, Andreu Comas-García, Marcela Aguilera-Barragán, Adriana Durham-González, Soledad Contreras-Vidales, Uciel Ochoa-Pérez, Alejandro Gómez-Gómez, Christian A. García-Sepúlveda, Daniel E. Noyola. (2010) Pandemic influenza A(H1N1) 2009 and respiratory syncytial virus associated hospitalizations. Journal of Infection 61:5, 382-390
    CrossRef

  79. 79

    Soo Youn Shin, Joon Hyung Kim, Hyun Su Kim, Young A Kang, Ha Gyung Lee, Jin Seok Kim, Jong-Koo Lee, Woo Kyung Kim. (2010) Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus. Pediatric Pulmonology 45:10, 1014-1020
    CrossRef

  80. 80

    Steven Black, Giovanni Della Cioppa, Anne Malfroot, Pantaleo Nacci, Uwe Nicolay, Michele Pellegrini, Etienne Sokal, André Vertruyen. (2010) Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis. Vaccine 28:45, 7331-7336
    CrossRef

  81. 81

    Monica M. Farley. (2010) 2009 H1N1 Influenza: A Twenty-First Century Pandemic With Roots in the Early Twentieth Century. The American Journal of the Medical Sciences 340:3, 202-208
    CrossRef

  82. 82

    Matheus Roriz-Cruz, Idiane Rosset, Manuel Montero-Odasso. (2010) LOWER MORTALITY FROM H1N1 INFLUENZA IN OLDER ARGENTINEANS: MEN MORE AFFECTED. Journal of the American Geriatrics Society 58:9, 1813-1815
    CrossRef

  83. 83

    Ankit Parakh, Amit Kumar, Virendra Kumar, Ashok Kumar Dutta, Shashi Khare. (2010) Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1): An Experience from a Tertiary Care Center in North India. The Indian Journal of Pediatrics 77:9, 981-985
    CrossRef

  84. 84

    Romina Libster, Kathryn M. Edwards. (2010) The Necessity of Influenza Vaccination in Children. Pediatric Annals 39:8, 490-496
    CrossRef

  85. 85

    Marc P. Girard, John S. Tam, Olga M. Assossou, Marie Paule Kieny. (2010) The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 28:31, 4895-4902
    CrossRef

  86. 86

    P.W. Orellano, J.I. Reynoso, O. Carlino, O. Uez. (2010) Protection of trivalent inactivated influenza vaccine against hospitalizations among pandemic influenza A (H1N1) cases in Argentina. Vaccine 28:32, 5288-5291
    CrossRef

  87. 87

    Cristian Launes, Susana Rives, Albert Català, Rubén Berrueco, Teresa Toll, Mireia Camós, Carmen Muñoz-Almagro, Juan J. García-García, Jesús Estella. (2010) Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. British Journal of Haematology 149:6, 874-878
    CrossRef

  88. 88

    Kelvin Kai-Wang To, Iris Wai-Sum Li, Ivan Fan-Ngai Hung, Vincent Chi-Chung Cheng, Kwok-Yung Yuen. (2010) Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management. Frontiers of Medicine in China 4:2, 147-156
    CrossRef

  89. 89

    Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. (2010) Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection. New England Journal of Medicine 362:18, 1708-1719
    Full Text

  90. 90

    Yael Shachor-Meyouhas, Imad Kassis. (2010) Petechial Rash With Pandemic Influenza (H1N1) Infection. The Pediatric Infectious Disease Journal 29:5, 480
    CrossRef

  91. 91

    Hagyung Lee, Yung A Kang, Hyun Su Kim, Su Yeun Shin, Jun Heung Kim, Jin Seok Kim, Sang-Bum Hong. (2010) Epidemiological Characteristics Based on the Underlying Diseases for the Deaths Related to Pandemic H1N1 Influenza in Korea. The Korean Journal of Critical Care Medicine 25:2, 83
    CrossRef

  92. 92

    H Frangoul, J Domm, M R Denison, C Calder, J Black. (2010) H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT. Bone Marrow Transplantation
    CrossRef

Letters